Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

February 26, 2019

Patent Application Number

15359012

Date Filed

November 22, 2016

Patent Citations

US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors

US Patent 10016348 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C

Patent Citations Received

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same

US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors

US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors

US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same

...

Patent Primary Examiner

Patent abstract

The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are FGFR3 inhibitors useful in the treatment of cancer and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10213427 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool